ICON

ICON, founded in Dublin in 1990, is a global life-science services company that accelerates the development of drugs and medical devices. Leveraging a worldwide network across 53 countries, ICON delivers end-to-end consulting, clinical research, regulatory, commercialization, and value-based healthcare solutions across therapeutic areas such as oncology and other specialties. The company distinguishes itself through a relentless focus on reducing time to market, cutting costs, and enhancing product quality, supported by a multidisciplinary team of experts. ICON's integrated portfolio spans clinical trials, patient recruitment, medical affairs, and global patient insights, enabling clients to bring life-saving therapies to patients more efficiently.